Renal tubular injury is present in acute inflammatory bowel disease prior to the introduction of drug therapy

Alimentary Pharmacology and Therapeutics

Volumn 15, Issue 8, 2001, Pages 1131-1137

  Fraser, J S ^a   Muller, A F ^a   Smith, D J ^b   Newman, D J ^a   Lamb, E J ^a  

^a KENT AND CANTERBURY HOSPITAL   (United Kingdom)

^b ST HELIER HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 MICROGLOBULIN; CREATININE; CRYSTALLIN; CYSTATIN C; MESALAZINE; N ACETYL BETA GLUCOSAMINIDASE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DISEASE ASSOCIATION; DISEASE MARKER; DRUG MONITORING; ENTERITIS; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY FUNCTION; KIDNEY INJURY; KIDNEY TUBULE; MALE; PRIORITY JOURNAL; PROTEINURIA;

ACETYLGLUCOSAMINIDASE; ADULT; AGED; AGED, 80 AND OVER; ALPHA-GLOBULINS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BIOLOGICAL MARKERS; CREATININE; CYSTATINS; FEMALE; HUMANS; INFLAMMATORY BOWEL DISEASES; KIDNEY DISEASES; KIDNEY TUBULES; MALE; MESALAMINE; METABOLIC CLEARANCE RATE; MIDDLE AGED; PROSPECTIVE STUDIES; PROTEINURIA;

EID: 0034928060     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.2001.01041.x     Document Type: Article

References (39)

1. What dose of 5-aminosalicylic acid (mesalazine) in ulcerative colitis?
2. Acute interstitial nephritis due to 5-aminosalicylic acid
3. Mesalazine induced interstitial nephritis
4. Interstitial nephritis associated with 5-aminosalicylic acid
5. 5-Amino-salicylic acid (5-ASA) and chronic tubulointerstitial nephritis in patients with chronic inflammatory bowel disease: Is there a link?
6. Late-onset interstitial nephritis associated with mesalazine treatment
7. Chronic interstitial nephritis due to 5-aminosalicylic acid
8. Mesangiocapillary glomerulonephritis associated with ulcerative colitis: Case reports of two patients
9. Proliferative glomerulonephritis associated with Crohn's disease
10. Glomerulonephritis associated with inflammatory bowel disease
11. Mesalazine associated nephrogenic diabetes insipidus presenting as weight loss
12. Mesalazine-associated interstitial nephritis: Twice in the same patient
13. Interstitial nephritis associated with the use of mesalazine in inflammatory bowel disease
14. Renal lesions associated with chronic ulcerative colitis
15. Regional enteritis: Associated visceral changes
16. Mesalazine-associated interstitial nephritis
17. Mesalazine and renal impairment
18. Serum creatinine as an index of renal function: New insights into old concepts
19. Microalbuminuria as a predictor of clinical diabetic nephropathy
20. Urinary enzymes and nephrotoxicity in humans
21. Diagnostic value of analysis of cystatin C and protein HC in biological fluids
22. Serum cystatin C determined by a rapid, automated particle-enhanced turbidimetric method, is a better marker than serum creatinine for glomerular filtration rate
23. Serum cystatin C measured by automated immunoassay: A more sensitive marker of changes in glomerular filtration rate than serum creatinine
24. Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: A randomised trial
25. A simple index of Crohn's disease activity
26. Colorimetric assays for N-acetyl-β-D-glucosaminidase and β-D-galactosidase in human urine using newly developed co-nitrostyryl substrates
27. Prevention of diabetic renal disease with special reference to microalbuminuria
28. Calculating correlation coefficients with repeated observations: Part 2 - Correlation between subjects
29. Tests of renal function in patients with quiescent colitis: Effects of drug treatment
30. Microalbuminuria in inflammatory bowel disease
31. Microalbuminuria correlates with intestinal histopathological grading in patients with inflammatory bowel disease
32. Renal function was not impaired with 5-aminosalicylic acid in rats and man
33. Renal proximal tubular dysfunction in Crohn's disease
34. Renal tubule damage: An extra-intestinal manifestation of chronic inflammatory bowel disease
35. Renal tubular dysfunction in patients with inflammatory bowel disease treated with aminosalicylate
36. Creatinine clearance and glomerular filtration rate
37. Time to scrap creatinine clearance
38. Cystatin C as a marker for glomerular filtration rate in pediatric patients
39. Improved prediction of decreased creatinine clearance by serum cystatin C: Use in cancer patients before and during chemotherapy